In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy

Current therapies against hepatitis B virus (HBV) do not reliably cure chronic infection, necessitating new therapeutic approaches. The T cell response can clear HBV during acute infection, and the adoptive transfer of antiviral T cells during bone marrow transplantation can cure patients of chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruse, Robert L., Shum, Thomas, Legras, Xavier, Barzi, Mercedes, Pankowicz, Frank P., Gottschalk, Stephen, Bissig, Karl-Dimiter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626922/
https://www.ncbi.nlm.nih.gov/pubmed/29018834
http://dx.doi.org/10.1016/j.omtm.2017.08.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626922/
https://www.ncbi.nlm.nih.gov/pubmed/29018834
http://dx.doi.org/10.1016/j.omtm.2017.08.006

Ejemplares similares